Xiang Jie Jiang from Winsted, CT, age 47

License Records

Xiang Jiang

License #:

PNT.047311 - Active

Issued Date:

Nov 1, 2013

Expiration Date:

Nov 1, 2018

Type:

Pharmacy Intern

Us Patents

Spirocyclic Anti-Migraine Compounds
view source
US Patent:

20070149502, Jun 28, 2007
Filed:

Jan 5, 2007
Appl. No.:

11/620253
Inventors:

Prasad Chaturvedula - Cheshire CT, US
Gene Dubowchik - Middlefield CT, US
Xiang Jun Jiang - North Haven CT, US
John Macor - Guilford CT, US
Graham Poindexter - Old Saybrook CT, US
Shikha Vig - Durham CT, US
International Classification:

A61K 31/551
A61K 31/55
A61K 31/541
A61K 31/5377
A61K 31/496
A61K 31/454
C07D 417/02
C07D 413/02
C07D 403/02
US Classification:

514210200, 514235200, 514235500, 514219000, 514217040, 514217050, 514227500, 514253010, 514254010, 514326000, 540575000, 540597000, 540598000, 544060000, 544129000, 544121000, 544360000, 544372000, 546207000, 546208000, 546209000, 546210000
Abstract:

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

Anti-Migraine Spirocycles
view source
US Patent:

20070149503, Jun 28, 2007
Filed:

Jan 5, 2007
Appl. No.:

11/620308
Inventors:

PRASAD CHATURVEDULA - Cheshire CT, US
Ling Chen - Middletown CT, US
Rita Civiello - Killingworth CT, US
Andrew Degnan - Rocky Hill CT, US
Gene Dubowchik - Middlefield CT, US
Xiaojun Han - Cheshire CT, US
Xiang Jun Jiang - North Haven CT, US
John Macor - Guilford CT, US
Graham Poindexter - Old Saybrook CT, US
George Tora - Meriden CT, US
Guanglin Luo - Madison CT, US
International Classification:

A61K 31/541
A61K 31/5377
A61K 31/497
A61K 31/496
A61K 31/53
A61K 31/506
A61K 31/454
C07D 403/02
C07D 417/02
C07D 413/02
US Classification:

514210200, 514227500, 514235200, 514235500, 514241000, 514252180, 514252190, 514275000, 514253010, 514254010, 514255050, 514252110, 514326000, 514319000, 514318000, 544060000, 544121000, 544129000, 544209000, 544295000, 544331000, 544360000, 544372000, 546207000, 546208000, 546209000, 546210000
Abstract:

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

Anti-Migraine Treatments
view source
US Patent:

20070232600, Oct 4, 2007
Filed:

Jan 5, 2007
Appl. No.:

11/620291
Inventors:

Ling Chen - Middletown CT, US
Prasad Chaturvedula - Cheshire CT, US
Rita Civiello - Killingworth CT, US
Andrew Degnan - Rocky Hill CT, US
Gene Dubowchik - Middlefield CT, US
Xiaojun Han - Cheshire CT, US
Xiang Jun Jiang - North Haven CT, US
George Karageorge - Portland CT, US
Guanglin Luo - Madison CT, US
John Macor - Guilford CT, US
Graham Poindexter - Old Saybrook CT, US
George Tora - Meriden CT, US
International Classification:

A61K 31/517
A61K 31/536
US Classification:

514230500, 514266100
Abstract:

The present invention relates to methods of treating neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors using pharmaceutical compositions comprising compounds of Formula (I)

Calcitonin Gene Related Peptide Receptor Antagonists
view source
US Patent:

20040204397, Oct 14, 2004
Filed:

Dec 5, 2003
Appl. No.:

10/729155
Inventors:

Prasad Chaturvedula - Cheshire CT, US
Ling Chen - Middletown CT, US
Rita Civiello - Killingworth CT, US
Charles Conway - Cheshire CT, US
Andrew Degnan - New Haven CT, US
Gene Dubowchik - Middlefield CT, US
Xiaojun Han - Cheshire CT, US
Xiang J. Jiang - Hamden CT, US
George Karageorge - Portland CT, US
Guanglin Luo - Madison CT, US
John Macor - Guilford CT, US
Graham Poindexter - Old Saybrook CT, US
George Tora - Meriden CT, US
Shikha Vig - Durham CT, US
International Classification:

A61K031/541
A61K031/5377
A61K031/53
A61K031/496
A61K031/454
US Classification:

514/210200, 514/227500, 514/235200, 514/252110, 514/254010, 514/253010, 514/255010, 514/326000, 514/252140, 514/254020, 514/254050, 514/241000
Abstract:

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.